| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.5 |